SCHEMBL14906969

SCHEMBL14906969

Nc1cc(Cl)ccc1-c1ccc(-c2ccc(Cl)cc2N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
TSHR P16473 4/20 0.56
CYP3A4 P08684 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
ALOX15 P16050 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
TP53 P04637 1/20 0.54
MAPK1 P28482 2/20 0.50
HPGD P15428 2/20 0.50
ALOX12 P18054 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
AHR P35869 2/20 0.41
S100A4 P26447 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12505481 0.89 SMN1; SMN2 (0.52) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL4148009 0.89 SMN1; SMN2 (0.46) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL358933 0.89 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL30839752 0.87 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL30839712 0.87 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL27185985 0.87 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL19244809 0.86 TAAR1 (0.55) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL357433 0.86 ALDH1A1 (0.44) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL2502464 0.85 TSHR (0.56) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15
SCHEMBL15622693 0.85 TSHR (0.46) ALDH1A1TSHRCYP3A4SMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160207774-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2016-07-21 US disclosed
US-20160207774-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2016-07-21 US disclosed
US-20160207774-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2016-07-21 US disclosed
US-20140301935-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2014-10-09 US disclosed
US-20140301935-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2014-10-09 US disclosed
US-20140301935-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2014-10-09 US disclosed
WO-2013061256-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS BASF SE (DE) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140301935-A1 OLIGOPHENYLENE MONOMERS AND POLYMERIC PRECURSORS FOR PRODUCING GRAPHENE NANORIBBONS PCBP1, GMNN, PCNA ALDH1A1 2853/4885TSHR 4581/4885CYP3A4 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.